(Q26862748)

15 August 2020

herpes zoster vaccine

1 reference

3

Myron J. Levin

1 reference

2

Michael N. Oxman

1 reference

4

Kenneth E. Schmader

1 reference

Mélanie Drolet

1

1 reference

Robert W. Johnson

5

1 reference

David Patrick

6

1 reference

James A. Mansi

7

1 reference

Marc Brisson

8

1 reference

language of work or name

1 reference

May 2013

1 reference

Human Vaccines & Immunotherapeutics

1 May 2013

10 references

23 March 2019

25 April 2019

20 June 2019

25 June 2019

22 July 2019

19 September 2019

21 October 2019

6 January 2020

15 August 2020

9 July 2022

11 references

23 March 2019

25 April 2019

20 June 2019

25 June 2019

22 July 2019

19 September 2019

21 October 2019

6 January 2020

15 August 2020

9 July 2022

9

1 reference

page(s)

1177-84

1 reference

issue

5

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

copyright license

10 references

23 March 2019

25 April 2019

20 June 2019

25 June 2019

22 July 2019

19 September 2019

21 October 2019

6 January 2020

15 August 2020

on focus list of Wikimedia project

9 July 2022

ScienceSource

0 references

cites work

Antiviral treatment for preventing postherpetic neuralgia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Epidemiology of varicella zoster virus infection in Canada and the United Kingdom

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Recommendations for the Management of Herpes Zoster

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Incidence of Herpes Zoster, Before and After Varicella‐Vaccination–Associated Decreases in the Incidence of Varicella, 1992–2002

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Acute Pain in Herpes Zoster and Its Impact on Health-Related Quality of Life

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study

21 March 2017

1 reference

https://api.crossref.org/works/10.4161/HV.23491

Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy

22 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Topical pain management with the 5% lidocaine medicated plaster--a review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Effectiveness of antiviral treatment on acute phase of herpes zoster and development of post herpetic neuralgia: review of international publications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

The impact of herpes zoster and post-herpetic neuralgia on quality-of-life

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Prevention of herpes zoster and its painful and debilitating complications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Clinical practice. Herpes zoster

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Sick but yet at work. An empirical study of sickness presenteeism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Pain and its persistence in herpes zoster

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3899157

NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia

28 September 2017

1 reference

The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales

21 January 2018

1 reference

Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: prospective prognostic study.

21 January 2018

1 reference

Incidence of herpes zoster, 1997-2002.

21 January 2018

1 reference

Acute pain in herpes zoster: the famciclovir database project

21 January 2018

1 reference

Risk factors for postherpetic neuralgia in patients with herpes zoster

21 January 2018

1 reference

The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults.

21 January 2018

1 reference

The burden of Herpes Zoster: a prospective population based study

21 January 2018

1 reference

Work and productivity loss related to herpes zoster.

21 January 2018

1 reference

Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans

21 January 2018

1 reference

21 January 2018

1 reference

Predicting and preventing post-herpetic neuralgia: are current risk factors useful in clinical practice?

21 January 2018

1 reference

Clinical and psychosocial correlates of post-herpetic neuralgia.

21 January 2018

1 reference

Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice.

21 January 2018

1 reference

Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales.

21 January 2018

1 reference

Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia.

21 January 2018

1 reference

Cost effectiveness of herpes zoster vaccine in Canada.

21 January 2018

1 reference

Health economic evaluation of a vaccine for the prevention of herpes zoster (shingles) and post-herpetic neuralgia in adults in Belgium.

21 January 2018

1 reference

The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom

21 January 2018

1 reference

Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: Adaptation of the brief pain inventory

21 January 2018

1 reference

Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study

21 January 2018

1 reference

12 December 2020

A prospective study of the herpes zoster severity of illness

1 reference

12 December 2020

Association between prodromal pain and the severity of acute herpes zoster and utilization of health care resources

1 reference

12 December 2020

Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

1 reference

12 December 2020

The pathology of Herpes Zoster and its bearing on sensory localisation

1 reference

12 December 2020

Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database

1 reference

12 December 2020

Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older

1 reference

12 December 2020

Herpes zoster: risk categories for persistent pain

1 reference

12 December 2020

The outcome of patients with herpes zoster

1 reference

12 December 2020

The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia

1 reference

12 December 2020

Pain and somatosensory dysfunction in acute herpes zoster

1 reference

12 December 2020

Postherpetic neuralgia

1 reference

12 December 2020

The well-being assessment for productivity: a well-being approach to presenteeism

1 reference

12 December 2020